Human Tissue Specimens

ProteoGenex supplies normal and diseased tissues in the following formats:

Inventory Tissue Specimens

Fresh Frozen Tissues

Fresh Frozen Tissues

Formalin-Fixed Paraffin-Embedded (FFPE) Tissues

Formalin-Fixed Paraffin-Embedded (FFPE) Tissues

FDA Tissue Panel

FDA Tissue Panel

Custom Collected Tissue Specimens

Tissue Microarray (TMA) Blocks

Tissue Microarray (TMA) Blocks

Human Single-Cell Suspensions

Human Single-Cell Suspensions

Normal tissue specimens are sourced from two main sources:
1) Normal adjacent tissues (NAT) to cancer and benign conditions.
NAT specimens are sourced at least 4 centimeters from necrosis or tumor tissue.
2) Normal Postmortem Tissues from clinically unremarkable postmortem donors.
Postmortem tissues are excised and frozen with a maximum postmortem interval (PMI) of 6 hours.
We aim for each PMI to be as short as possible.

All normal tissue specimens are confirmed normal by pathology.

Each normal tissue is accompanied by the following information:
  • Sample ID#
  • Age
  • Sex
  • Ethnicity
  • Date of surgery/autopsy
  • Cause of death (if applicable)
  • Postmortem interval (PMI)
Primary tumor tissue specimens are sourced from dozens of cancer types.
All primary tumor tissues are excised before chemotherapy or radiotherapy, unless noted otherwise.
Each primary tumor tissue is accompanied by the following information (available if applicable**)
  • Sample ID#
  • Age
  • Sex
  • Ethnicity
  • Diagnosis
  • Histological diagnosis
  • Grade (G1-G4) of Differentiation**
  • TNM Staging**
  • Stage**
  • Biomarker status (ER, PR, Her2, PSA, etc.)**
  • Location of distant metastases**
  • Number of analyzed lymph nodes**
  • Number of positive (metastatic) lymph nodes**
  • Tumor size**
  • Date of surgery/autopsy
  • Treatment history**

Metastatic tissue specimens are sourced from dozens of cancer types.

Metastatic tissues are available from:
1) Positive (Metastatic) Lymph Nodes
2) Distant Metastatic Tumor Tissues

All metastatic tumor tissues are excised before chemotherapy or radiotherapy, unless noted otherwise.

Each metastatic tumor tissue is accompanied by the following information (available if applicable**)
  • Sample ID#
  • Age
  • Sex
  • Ethnicity
  • Diagnosis
  • Histological diagnosis
  • Grade (G1-G4) of Differentiation**
  • TNM Staging**
  • Stage**
  • Biomarker status (ER, PR, Her2, PSA, etc.)**
  • Location of distant metastases**
  • Number of analyzed lymph nodes**
  • Number of positive (metastatic) lymph nodes**
  • Tumor size**
  • Date of surgery
  • Treatment history**
Benign tumor tissue specimens are sourced from a variety of benign conditions.
Each benign tissue specimen is accompanied by the following information:
  • Sample ID#
  • Age
  • Sex
  • Ethnicity
  • Diagnosis
  • Histological diagnosis
  • Date of surgery
  • Medical history
Diseased tissue specimens are collected from a wide array of clinically confirmed diseases.
Diseased tissue specimens are sourced from two main sources:
1) Living, Diseased Donors
Diseased tissues from live donors are only available if tissue removal is critical to diagnosis or treatment.
2) Diseased Postmortem Tissues from postmortem donors.
Postmortem tissues are excised and frozen with a maximum postmortem interval (PMI) of 6 hours.
We aim for each PMI to be as short as possible.
Each diseased tissue is accompanied by the following information:
  • Sample ID#
  • Age
  • Sex
  • Ethnicity
  • Diagnosis
  • Histological diagnosis
  • Date of surgery/autopsy
  • Cause of death (if applicable)
  • Postmortem interval (PMI)
  • Medical history
  • Treatment history (if applicable)
  • Any other relevant clinical information

Call or email our team to discuss your custom project or ask about specimen availability in our extensive biorepository.
or
You can also Order Specimens Online.